UMANICK has been Selected to Join the FIWARE Accelerator VIP Programme

UMANICK has been selected among over 800 European start-ups from different sectors belonging to FIWARE Accelerator to enter its VIP Programme. UMANICK entered the eHealth accelerator of the European Commission, FICHe (Future Internet Challenge eHealth), in January 2015. FICHe is one of 16 FIWARE accelerators operating in different areas, being the only one dedicated to health.

In late 2015, the FI-PPP (The Future Internet Public Private Partnership) introduced the FIWARE Accelerator VIP Programme. It is a set of specific actions to give special support to a small number of emerging companies identified by FI-PPP advisers as businesses with great business development, innovation and internationalization potential.

Of the 100 start-ups that were eligible to join the VIP Programme, only 15 were selected. Two of these selected companies, among which is UMANICK, belong to FICHe and are Spanish.

"13% of the companies in the VIP Programme belong to FICHe, representing 6% of all existing FIWARE accelerators. A real success for FICHe. The two FICHe companies chosen are Spanish and are currently being supported by the Murcia Health Service for its 'Living Lab'. This shows that the Murcia Health Service is doing an excellent job promoting information technology in health," has highlighted Emilio Gallego, CEO of UMANICK.

Specifically, UMANICK is carrying just a pilot project for safe patient identification using biometric technologies in the Onco-Hematology Day Hospital of the University Hospital Virgen de la Arrixaca, in Murcia. In the words of Gorka Sanchez Nanclares, Responsible for Innovation at Murcia Health Service: "The pilot has been successful in regards to acceptance, both among professionals, who have incorporated the fingerprint and iris verification to their usual practice, and among patients, who have mostly chosen this access path versus the usual, in the voluntary approach offered to them within this FICHe research project, part of the Murcia Health Service's 'Living Lab'."

The other start-ups selected for the VIP Programme are: Zebra (Belgium), AlzhUp (Spain), Intoino (Italy), Measurence (Italy), Donkey Republic (Denmark), Ususty (Hungary), Parcellab (Germany), OEEX (Germany), Urbi (Germany), Neuroathome (Spain), Everimpact (France), Sensape (Germany), InReception (Italy) and Leeluu (Finland).

All these start-ups will participate together with UMANICK in a Bootcamp with specialised investors that will take place from the 4th to the 6th of May in Milan.

About UMANICK
At UMANICK we are committed with the safety of persons and organizations. Our biometric software with fingerprint, face, voice and iris recognition, allows people to identify themselves in an easy and secure way. Something impossible with the traditional methods of cards and passwords.

Our main mission is to safeguard patient safety in the healthcare sector. Our solutions avoid patient harm stemming from identification errors in healthcare processes at hospitals and medical centres. We also eliminate fraud by patient identity theft, reduce healthcare spending, and improve the image and reputation of the hospital.

Other sectors that benefit from our secure identification biometric systems are Banking and means of payment, Public Administration and Education.

More information on www.umanick.com

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...